web analytics
August 4, 2015 / 19 Av, 5775
At a Glance

Posts Tagged ‘Technion’

Qualcomm Co-Founder Donates $50 Million to Technion

Monday, June 15th, 2015

Qualcomm cofounder Prof. Andrew Viterbi said he is donating $50 million to the Faculty of Electrical Engineering at the Technion.

Viterbi, a native of Italy who grew up in the United States, has donated to Technion in the past, but the new grant makes him the university’s largest private donor.

This is not Viterbi’s first donation to the Technion, but it is his largest.

He co-founded the Qualcomm chip company and invented the Viterbi Algorithm for decoding signals.

Prof. Viterbi’s visisted and lectured at Technion in 1967, when he was on Sabbatical from UCLA, and he was granted an honorary Doctorate in 2000, when also was named a Technion Distinguished Visiting Professor of Electrical Engineering.

Technion President Prof. Peretz Lavie said:

This is the greatest honor for a professor at the Technion, and has been granted up until now to only six people, three of whom were Nobel Prize winners. The degree enables Viterbi to come to the Technion whenever he wants, and there was a period when he visited here every year.

Viterbi said after announcing the latest donation, “Technion electrical engineering graduates are in large part responsible for creating and sustaining Israel’s high-tech industry, which has been essential for Israel’s economic success.”
Technion graduates have been responsible for founding and managing 1,602 high-tech companies, he added.
The grant will enable Technion to enlarge the Faculty of Electrical Engineering.

Technion Scientists Reach Breakthrough in Cancer Study

Monday, April 13th, 2015

Israeli scientists are closer than ever to finding a way to beat back cancer at the Technion Israel Institute of Technology. The findings of the new study were published last week in the journal CELL.

The researchers discovered two cancer-suppressing proteins, according to information released via PR Newswire. They carried out the study in the world-famous laboratory of Nobel Prize laureate Professor Aaron Ciechanover, president of the Israel Cancer Society.

The team was led by research associate Dr. Yelena Dravtsova-Ivantsiv and worked together with physicians from Rambam, Carmel and Hadassah Medical Centers, all of whom are studying tumors and their treatments.

KPC1 – a vital pathway in the life of the cell – is responsible for the degradation of defective proteins that could damage the cell if not removed. The system tags these defective proteins and send them to the proteasome cellular complex to be destroyed.

The system also removes functional and healthy proteins that are no longer needed, thus regulating the processes the proteins control.

By the time a protein reaches the proteasome system it is already broken down but there are exceptions.

This study examined “p105” – a long precursor of a key regulator in a cell called “NF-kB” which has been identified as a link between inflammation and cancer.

The first person to suggest such a link was Dr. Rudolph Virchow, a German pathologist, in 1863. His research has been repeatedly confirmed over the years, and since the discovery of NF-kB 30 years ago, there have been many articles linking the cell to malignant transformation in tumors in various parts of the body.

The current research is focused on deciphering the decision-making mechanism that determines which process will be applied to the NF-kB cell. There are two, both connected to the “ubiquitin system” which produces a protein that greatly restricts the development of cancerous tumors.

1. Either a “ubiquitin” system component called KPC1 becomes involved and attaches ubiquitin to p105, thus shortening the protein to become “p50” ; or 2. Ubiquitination is mediated without KPC1 and instead by another component in the system, and p105 is degraded and destroyed completely.

In other words, the presence of high levels of KPC1 and p50 would mean the malignant growth is suppressed and healthy tissue appears to be protected, according to the present findings in the study.

The current research was conducted on lab mice as well as samples of human tumors. A strong connection was found between the suppression of malignancy and the level of the two proteins.

Professor Aaron Ciechanover, president of the Israel Cancer Society, noted that many more years will be required “to establish the research and gain a solid understanding of the mechanisms behind the suppression of the tumors. The development of a drug based on this discovery is a possibility, although not a certainty, and the road to such a drug is long and far from simple.”

Ciechanover won the Nobel Prize in chemistry in 2004, together with Professors Avram Hershko (also from Technion) and Irwin Rose of the Fox Chase Cancer Center, for the discovery of the ubiquitin system. The current line of research is a continuation of that work.

Technion’s Rube Goldberg Machine Passover Seder

Tuesday, March 24th, 2015

AOL Partners with Cornell Tech to Fund New Labs in New York, Israel

Sunday, November 16th, 2014

NEW YORK (JTA) — A graduate school cofounded by Cornell University and Israel’s Technion is launching a research lab with money it received from the AOL Internet media corporation.

The New York City-based Jacobs Technion-Cornell Institute (part of the Cornell NYC Tech graduate school), which was born out of a 2011 collaboration between the upstate New York university and the Haifa one, announced the new lab’s opening on Wednesday.

The lab, called “Connected Experiences,” or ConnX, will last four years and is funded by a “multimillion” dollar gift from AOL. The exact amount was not disclosed.

The lab will operate in both Israel and New York, and will allow researchers to explore technologies in areas including communication and coordination, food and wellness, education and safety, and information and entertainment.

“The partnership with AOL will allow Cornell Tech and Technion researchers access to resources — platforms and engineering and product knowledge — that is not readily available in academic settings,” said Dan Huttenlocher, dean of Cornell Tech, in a statement.

The gift also supports a fellowship program for graduate students, half of them to be female, in New York and Israel. Faculty in the new ConnX lab will include Shiri Azenkot and Serge Belongie at Cornell Tech, and Anat Rafaeli, Nir Ailon and Roi Reichart at Technion.

North American Medical Students Thrive in Diverse Region

Monday, June 9th, 2014

The sunny shore of Haifa’s bay usually imbues images of ships, sand and thoughts of carefree days. Yet gowns of black and green dotted the periphery, as many new physicians received their coveted diplomas and entered the medical profession.  The unique location of these rigorous studies aided to the nature of the student body, captured in the commencement ceremony.

Students, parents and friends filled the auditorium in the main campus of Technion, Israel’s leading technical university often dubbed the MIT of the Middle East, for the TeAMS class of 2014’s culminating ceremony. Dr. Andy Levy, dean of the overseas medical program reflected on this year’s graduating class. “The class has excelled in maintaining an environment at the medical school where students achieved academic strides in every measurable parameter,” Levy stated. Rooted in an atmosphere of professionalism, the students maintained a sense of camaraderie throughout the stressful years of medical school, often burning the midnight oil in group study sessions and communal meals.

The class of 2014 scored impeccably well in their match results, setting a very high standard for the program. Students placed in conventionally difficult specialties in residencies affiliated with the most prestigious programs in the United States; including Harvard University’s Mount Auburn Hospital, New York Presbyterian Hospital of Cornell University, University of Pittsburgh, Mount Sinai Medical Center, Mayo Clinic and Cleveland Clinic, among numerous others.

Aside from high test scores and impressive placements, the graduates at TeAMS had the unique opportunity to engage in their first practical medical encounters with varied and diverse populations. TeAMS’ students receive their initial exposures to rounds and medicine “on the job” at Rambam Health Care Campus, which has more than 2,130,000 people in their regional span. At least 1,175,000 of these people are Jewish, while 655,000 are Muslim, 123,000 are Christian, 123,000 are Druze and another 75,000 are not affiliated with a religion.

Students at TeAMS gained exposure to diverse sectarian groups first hand, as they practiced on patients from differing backgrounds, an experience which has affected many.

As Olivia Diamond New York native and class of 2014 graduate explained, “We were immersed almost immediately into the goings-on of hospital life. We got to watch procedures and shadow doctors on their rounds.” Diamond waves farewell to Haifa as she departs for Harvard University’s Mount Auburn Hospital to begin her residency in internal medicine.

Josh Gelleris, class of 2014 and California native, explained that coming to a different region affected him on a personal level. “One of the reasons I chose to study in Israel was so that I could experience a new culture,” Gelleris said. “I believed that studying in a new place would give me the opportunity to add a dimension to my educational experience that I thought would be important to my personal development.” Gelleris leaves Israel to begin his residency in internal medicine at New York Presbyterian Hospital of Cornell University.

At the commencement ceremony, Dr.Levy mirrored these sentiments by stressing the importance of treating each patient compassionately, no matter what their background. As Dr. Levy said, “I would like to bless each of you with a peace within yourselves, strive always to work to increase hope and strengthen your patients, not only physically through the knowledge you have accumulated but also by caring for them with empathy.”

Alexis Steinberg, originating from Canada and valedictorian for TeAMS class of 2014, described how exposure to this multicultural experience has influenced her outlook. “As physicians, our job entails more than just prescribing medications, especially since many diseases cannot be cured. In chronic diseases like, Alzheimer’s, ischemic heart disease, and diabetes mellitus, we are either just improving symptoms or increasing the quality of life for a patient. So, we need to really understand who the patient is in order to perform the art of healing, something that was conveyed to us while living in a foreign land.”

How to Become the Next President (of Israel)

Wednesday, April 2nd, 2014

Doug brings back NOBEL PRIZE WINNER DAN SCHECHTMAN, who is running to be the NEXT PRESIDENT OF ISRAEL.

Dan Shechtman (Hebrew: דן שכטמן) (born January 24, 1941 in Tel Aviv) is the Philip Tobias Professor of Materials Science at the Technion – Israel Institute of Technology, an Associate of the US Department of Energy’s Ames Laboratory, and Professor of Materials Science at Iowa State University. He was awarded the 2011 Nobel Prize in Chemistry for “the discovery of quasicrystals.”

Friedman Praises Israel’s Academic Freedom, then Urges Its Termination

Wednesday, February 19th, 2014

Today’s NY Times Columnist Tom Friedman’s “Breakfast Before the MOOC” praises a Technion pan-Arabic MOOC (massive online open course), yet another example of Israel’s inclusive approach to Arab students everywhere, and then, on the same page, calls for curtailing that success story in Judea and Samaria, which would mean the end of those freedoms for local Palestinians.

It’s sinister stuff.

My first email this morning came from the American Technion Society, practically jumping up and down on my desk, screaming: The Technion Featured in Tom Friedman’s Column!

Friedman described the Technion’s groundbreaking Arabic-language MOOC (massive online open course), with some 4,800 students who have signed up from Egypt, Syria, Saudi Arabia, Jordan, Iraq, Kuwait, Algeria, Morocco, Sudan, Tunisia, Yemen, Pakistan, the United Arab Emirates and the “West Bank.”

Friedman then comments: “Arab dictators so underestimated their people for so long. That’s what fueled the Arab awakening. It makes you weep for the wasted generations and pray this will be the last of them.”

And then he concludes: “This story is a useful reminder that Israel… has its lows, like the occupation … and its highs, like the [MOOC in Arabic].”

So that the conclusion of a mile-long column describing Israel as an oasis of knowledge and academic freedom for Arabs, is that Israel must end the “occupation,” which includes Ariel University in Samaria, with a massive enrollment of Palestinians who are given the same opportunities as Israelis.

These Palestinian students must now go back under the rule of Arab dictators, to follow Friedman’s logic.

Anav Silverman of the Tazpit News Agency reported here in December that Arab students make up 20% of the Technion’s student body.

This year’s valedictorian was 27-year-old Muslim woman, a medical student, Mais Ali-Saleh, who graduated from the Technion’s medical school. Ali-Saleh grew up in a small village near Nazareth.

What emerges from Silverman’s report is not only the obvious fact that the only country in the Middle east where Mais Ali-Saleh and other Arab women can excel academically is Israel, but that it is also the only country in the region where any Arab scientist can engage in valuable research. Rather than being the “apartheid state” for Arabs, Israel turns out to be a haven of democratic and academic freedom for Arabs.

But people like Tom Friedman can’t get over their desire to eradicate the Jewish presence in Judea and Samaria, no matter how productive and beneficial it is, and to replace it with Arab rule, no matter how tyrannical and repressive.

Printed from: http://www.jewishpress.com/news/breaking-news/friedman-praises-israels-academic-freedom-then-urges-its-termination/2014/02/19/

Scan this QR code to visit this page online: